About Alderys
Alderys is a company based in Orsay (France) founded in 2010 was acquired by Givaudan in May 2020. Alderys offers products and services including G-DESIGNER, GENOSOFT, SPRINT-CATALYST, and EVOLEV. Alderys operates in a competitive market with competitors including Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others.
- Headquarter Orsay, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alderys
Alderys offers a comprehensive portfolio of products and services, including G-DESIGNER, GENOSOFT, SPRINT-CATALYST, and EVOLEV.
Software for designing biological processes in chemical production.
Tool for genetic modifications in sustainable compound development.
Platform for speeding up catalytic reactions in industrial applications.
System for evolving biological systems for chemical innovation.
Funding Insights of Alderys
Detailed funding history for Alderys
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Alderys
Alderys has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Givaudan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Flavor and fragrance ingredients are supplied to firms and retailers.
|
Locked | Locked | Locked |
Investor details for Alderys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alderys
Investment portfolio details for Alderys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alderys
Detailed financials for Alderys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alderys Comparisons
Peer comparison for Alderys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alderys
Alderys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
Detailed competitors of Alderys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alderys
Complete news archive for Alderys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alderys
Alderys was founded in 2010.
Alderys is headquartered in Orsay, France. It is registered at Orsay, Essonne, France.
Alderys is focussed on developing technologies to the micro-organic biological engineering of profitable chemical compounds from renewable plant resources. It has developed solutions to improve yeast cells to transform them into veritable micro production units. Its approach is based on the specialized development of 3 technologies in the domains of biological engineering, molecular improvement of enzymatic catalysts and the development of microbial populations. It has also developed its own genome assembly software interfaced with numerous databases. It claims that its products can be used for animal nutrition, commodity chemicals and pharmaceutical industry.
Alderys's top competitors include Syngenta, Sutro Biopharma and Avidity Biosciences.
Alderys offers G-DESIGNER, GENOSOFT, SPRINT-CATALYST, and EVOLEV.
Alderys has 1 investor. Key investors include Givaudan.